Skip to content

Gastrointestinal Physiological Conditions in Obesity and After Bariatric Surgery

Gastrointestinal Physiological Conditions in Obesity and After Bariatric Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03783052
Acronym
GASTON
Enrollment
40
Registered
2018-12-20
Start date
2018-02-01
Completion date
2021-03-30
Last updated
2022-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Bariatric Surgery Candidate

Brief summary

Over the years, obesity has become a major public health concern. The increasing rates of obesity are associated with an enhanced demand for weight-loss with bariatric surgery as a treatment option. Bariatric surgery procedures alter the anatomical structure of the gastrointestinal tract, which contributes to the postoperative weight loss. However, it is not sure how obesity and the anatomical alterations of bariatric surgery affect the gastrointestinal physiology including gastrointestinal pH, gastric emptying, intestinal transit time and concentration of enzymes.

Detailed description

During the visit in the obesity clinic, eligible patients will be approached for participation by the sub-investigator. Interested patients will receive information regarding the study and receive the information sheet containing the informed consent form. After signing the informed consent form, volunteers will be invited to come to the clinical research center: * Healthy volunteers: Gastrointestinal physiology will be analyzed during two visits using a telemetric capsule. During the first visit, the physiological conditions of interest will be analysed in fasted state using the telemetric capsule. During the second visit, the physiological conditions of interest will be analysed in fed state using the telemetric capsule. * Obese volunteers: Gastrointestinal physiology will be analyzed during two visits using a telemetric capsule. During the first visit, the physiological conditions of interest will be analysed in fasted state using the telemetric capsule. During the second visit, the physiological conditions of interest will be analysed in fed state using the telemetric capsule. * Obese volunteers: Gastrointestinal physiology will be analyzed during three visits using a telemetric capsule, scintigraphy and via the collection of gastrointestinal samples. During the first visit, the physiological conditions of interest will be analysed in fasted state using the telemetric capsule. During the second visit, gastrointestinal samples will be collected at the level of the stomach, the duodenum and jejunum via aspiration through multiple lumen catheters in fasted and fed state. During the third visit, gastric emptying will be observed via scintigraphy in fed state. * Volunteers after Sleeve Gastrectomy: Gastrointestinal physiology will be analyzed during three visits using a telemetric capsule, scintigraphy and via the collection of gastrointestinal samples. During the first visit, the physiological conditions of interest will be analysed in fasted state using the telemetric capsule. During the second visit, gastrointestinal samples will be collected at the level of the sleeve, the duodenum and jejunum via aspiration through multiple lumen catheters in fasted and fed state. During the third visit, gastric emptying will be observed via scintigraphy in fed state. * Volunteers after Roux-en-Y gastric Bypass: Gastrointestinal physiology will be analyzed during three visits using a telemetric capsule, scintigraphy and via the collection of gastrointestinal samples. During the first visit, the physiological conditions of interest will be analysed in fasted state using the telemetric capsule. During the second visit, gastrointestinal samples will be collected at the level of the pouch, the Roux limb and the common limb via aspiration through multiple lumen catheters in fasted and fed state. During the third visit, gastric emptying will be observed via scintigraphy in fed state.

Interventions

DEVICESmartPill in fasted state

SmartPill administration in fasted state

DEVICESmartPill in fed state

SmartPill administration in fed state

OTHERAspiration

Aspiration of gastrointestinal samples in fasted and fed state

Gastric emptying scintigraphy in fed state

Sponsors

Universitaire Ziekenhuizen KU Leuven
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

\- 18 years or older

Exclusion criteria

* History of gastric ulcers * Disorders of swallowing * Suspected strictures, fistulas or physiological GI obstruction. * GI surgery within past three months * Severe dysphagia to food or pills * Crohns disease or diverticulitis * Use of implanted or portable electro-mechanical medical devices * Known intolerance to the SmartPill device * Known food allergies to any component of the meal * History of multiple bariatric surgeries * Pregnant or lactating women

Design outcomes

Primary

MeasureTime frameDescription
Gastrointestinal pH0-7 daysGastrointestinal pH (pH values)
Concentration of bile acids1 dayConcentration of bile acids
Gastric emptying time2 hoursGastric emptying time
Gastrointestinal Temperature0-7 daysGastrointestinal Temperature (°C)
Gastrointestinal Pressure0-7 daysGastrointestinal Pressure (mmHg)

Secondary

MeasureTime frameDescription
Gastrointestinal transit times0-7 daysGastric Emptying Time (hours), Small Bowel Transit Time (hours), Colonic Transit Time (hours) and Whole Gut Transit Time (hours)
Gastrointestinal motility0-7 daysContractions per minute

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026